Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6501
PUT
YieldMax TSLA Option Income Strategy ETF
TSLY
$670M
| $1.48M | ﹤0.01% |
39,420
+14,600
| +59% | +$590K |
|
6502
XPEL
XPEL
$1.38B
| $1.48M | ﹤0.01% |
29,621
-81,440
| -73% | -$3.4M |
|
6503
CALL
ProShares Ultra Bitcoin ETF
BITU
$351M
| $1.48M | ﹤0.01% |
66,900
-103,300
| -61% | -$4.02M |
|
6504
CALL
Methanex
MEOH
$4.43B
| $1.48M | ﹤0.01% |
37,200
-76,100
| -67% | -$2.83M |
|
|
RBIL
6505
F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF
RBIL
$155M
| $1.47M | ﹤0.01% |
29,680
+24,602
| +484% | +$1.23M |
|
6506
PUT
ChargePoint
CHPT
$152M
| $1.47M | ﹤0.01% |
221,960
-90,120
| -29% | -$852K |
|
6507
PUT
AnaptysBio
ANAB
$1.77B
| $1.47M | ﹤0.01% |
30,400
+23,400
| +334% | +$912K |
|
6508
iShares MSCI Mexico ETF
EWW
$1.81B
| $1.47M | ﹤0.01% |
+21,256
| New | +$1.44M |
|
6509
PUT
Terex
TEX
$7.7B
| $1.47M | ﹤0.01% |
27,600
-33,000
| -54% | -$1.67M |
|
6510
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.36B
| $1.47M | ﹤0.01% |
12,403
+9,484
| +325% | +$1.13M |
|
|
SVM
6511
PUT
Silvercorp Metals
SVM
$2.64B
| $1.47M | ﹤0.01% |
176,500
+300
| +0.2% | +$2.18K |
|
6512
Bank of Montreal
BMO
$130B
| $1.47M | ﹤0.01% |
+11,337
| New | +$1.44M |
|
|
BBBY
6513
PUT
Bed Bath & Beyond
BBBY
$415M
| $1.47M | ﹤0.01% |
269,300
-79,400
| -23% | -$576K |
|
6514
PUT
Saic
SAIC
$5.36B
| $1.47M | ﹤0.01% |
14,600
-12,500
| -46% | -$1.19M |
|
|
RZLV
6515
CALL
Rezolve AI
RZLV
$1.04B
| $1.47M | ﹤0.01% |
571,700
+268,100
| +88% | +$1.01M |
|
6516
Enanta Pharmaceuticals
ENTA
$374M
| $1.47M | ﹤0.01% |
+93,158
| New | +$1.18M |
|
6517
CALL
Vanguard Health Care ETF
VHT
$18.9B
| $1.47M | ﹤0.01% |
5,100
-4,200
| -45% | -$1.17M |
|
|
TRST
6518
Trustco Bank Corp NY
TRST
$977M
| $1.47M | ﹤0.01% |
35,504
+7,362
| +26% | +$293K |
|
6519
TRI-Continental Corp
TY
$1.91B
| $1.47M | ﹤0.01% |
+44,873
| New | +$1.52M |
|
6520
Xtrackers S&P 500 ESG ETF
SNPE
$2.95B
| $1.47M | ﹤0.01% |
+23,462
| New | +$1.44M |
|
6521
VanEck ChiNext Innovators ETF
CNXT
$118M
| $1.46M | ﹤0.01% |
33,467
-71,320
| -68% | -$3.04M |
|
6522
Invesco ESG NASDAQ 100 ETF
QQMG
$206M
| $1.46M | ﹤0.01% |
34,540
-3,925
| -10% | -$166K |
|
6523
CALL
Eve Holding
EVEX
$927M
| $1.46M | ﹤0.01% |
366,800
+351,700
| +2,329% | +$1.55M |
|
6524
PUT
Travere Therapeutics
TVTX
$5.99B
| $1.46M | ﹤0.01% |
38,300
-104,700
| -73% | -$3.4M |
|
|
DAWN
6525
PUT
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.46M | ﹤0.01% |
+157,000
| New | +$1.31M |
|
Similar funds
Ken Griffin's Q4 2025 Portfolio in Review
As of Q4 2025, Ken Griffin held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Ken Griffin's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Ken Griffin added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Ken Griffin's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Ken Griffin fully exited WEX in Q4 2025, selling an estimated $131M.
- Ken Griffin's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Ken Griffin opened 2,078 new positions and closed 2,191 in Q4 2025.
- Ken Griffin's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.